<img src="https://ml.globenewswire.com/Resource/Download/418fe8d1-a6a4-4025-84ba-56f14ee83865?size=2" nborder="0" align="left" hspace="5" vspace="5" title="IMDX Logo.png" alt="Insight Molecular Diagnostics Inc."/>NASHVILLE, Tenn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. iMDx will host a live Zoom webinar to discuss the company's financial results at 2:00 pm PT / 5:00 pm ET that same day. The live webinar to discuss financial results, followed by Q&amp;A, will be accessible via registration at the following link: <a href="https://www.globenewswire.com/Tracker?data=6SJrFBCbkY0giijW1MY24GAbSvNN8er0PSHz8OneUBL-O3fbjqYhmhySUMkS5-PXBLai8zYDdB6sXKzet8BMLEIlut8Gmy6g_Y3e6yIT7hmLtCAms9GNrp00cFt8Yfn9sUvHLfNTCxofqaQAkzONbsfSkm-sJwFkcwPsrMVJloA=" rel="nofollow" target="_blank" title="iMDx Q2 2026 Earnings Webinar.">iMDx Q2 2026 Earnings Webinar.</a> An archived replay will be available after the call concludes on iMDx’s website within the Investors/<a href="https://www.globenewswire.com/Tracker?data=CpIQC3Jpwb9czmPkRsqKuwpkExXR0w7H1khJvxbaFHkQzG29Xef9GsXXbjbbM4UoEtV6W23TKLt9qGG2q3q2whIdJmGqLkgMc-yCs3zt8SyggP12P-dlXMnfTftYiFsRrx6aJwf7qpJKGZfNEIzkLg==" rel="nofollow" target="_blank" title="Events &amp; Presentations">Events &amp; Presentations</a> section. Attendance at 11th Annual Needham Virtual MedTech &amp; Diagnostics 1×1 Conference Separately, on August 11th, Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will participate in the 11th Annual Needham Virtual MedTech &amp; Diagnostics 1x1 Conference, being held August 10-11, 2026. iMDx management will be conducting virtual one-on-one meetings on August 11th with investors registered for the conference. Investors wishing to book a meeting are encouraged to reach out to their Needham sales representative. About Insight Molecular Diagnostics Inc. Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit <a href="https://www.globenewswire.com/Tracker?data=VuklFyfxXad2DEeswllX2h-Zl2lek5Qhar6x_a30bmMuA3B9ifb8TTygU-cqcPTb_DQ57ci0XcvGZg3LgiE4HW6IkPJTqv9aAPUi9-zEY9gIjtaaNwHcFFe8MNspUTcX" rel="nofollow" target="_blank" title="">https://investors.imdxinc.com/</a> for more information. GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc. Investor Contact: Douglas Farrell LifeSci Advisors LLC <a href="https://www.globenewswire.com/Tracker?data=bS7ePj8dKbjQhrAgo2kOmUCKV8cpkM2sN6gtlhuwsIMFKxJ7YyWzC0f7FDO1eBxTo5H-vLhc1jgMq3wf2cWXWm7ZXm9Bjjf34dzSxZAjqJxAhPCc6EqZ5gMQgVq15r-H" rel="nofollow" target="_blank" title="imdx@lifesciadvisors.com">imdx@lifesciadvisors.com</a>  <img height="1.0px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/d49bc674-8acc-48ad-bdb8-1d35f9fe6536/image2.gif" width="1.0px" data-dpi="96" data-filename="image2.gif" /> <img height="1.0px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/81c92330-e659-4e67-9a62-040ee0e97761/image3.gif" width="1.0px" data-dpi="96" data-filename="image3.gif" /> <img alt="" src='https://ml.globenewswire.com/media/MDk4ZjU0ZDQtYjc1Yi00YWNjLWIxNjgtY2ZjMTEyNGUwZDZiLTUwMDA1MTg5MC0yMDI2LTA4LTA0LWVu/tiny/Insight-Molecular-Diagnostics-.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn